The national coverage determination explicitly outlines patient, clinician, and facilities criteria for qualifying procedures ...

Mamas Mamas, Ruben de Winter, and Paul Knaapen discuss the results of the PROCTOR trial, which explored native vessel versus ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.